| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
12-03-2014, 01:53 AM
|
#1 | |||
|
||||
|
Member
|
I just stumbled across this today. A new drug has been tested on mice at UC Riverside and New York's Rockefeller University.
It appears to reverse damage by reducing inflammation and rebuilding myelin. They suggest clinical trials will start soon. But that's another 10 years before it makes it on the market, right? (if all goes well) By the way, how did they figure out how to give MS to mice? Isn't it called EAE? Are we that similar to mice? http://www.gizmag.com/indazole-chlor...toms-ms/35020/
__________________
On Tysabri and love it. . |
|||
|
 Reply With Quote
|
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| Skin cancer drug reverses Alzheimer's in mice | Parkinson's Disease | |||
| Skin cancer drug reverses Alzheimer's in mice | Alzheimer's Disease | |||
| FYI - gene therapy reverses diabetic neuropathy in mice | Peripheral Neuropathy | |||
| Anti-myelin antibodies not assoc. w. progression to definite MS | Multiple Sclerosis | |||
New drug reverses MS progression in mice - rebuilds myelin
Threaded Mode